Deguchi S, Shimatani K, Tada T, Nakashima K, Yasuda T
Analytical Research Laboratories, Fujisawa Pharmaceutical Company, Ltd., Osaka, Japan.
J Pharm Sci. 1993 Jul;82(7):734-6. doi: 10.1002/jps.2600820712.
A new cholecystokinin-A antagonist, (S)-N-[1-(2-fluorophenyl)- 3,4,6,7-tetrahydro-4-oxo-pyrrolo[3,2,1-jk][1,4]benzodiazepine-3-yl]- 1H-indole-2-carboxamide (FR120480; 1), is a chiral compound that shows considerable solvent dependence of its optical rotation. Not only the absolute values, but also the signs (+ or -) for this compound change in various solvents. The optical rotation of 1 inherently correlated to the electron donating property characterized by donor number of the solvent. The 1H NMR study implied that hydrogen bonds were formed between electron donor groups of the solvents and the NH groups of indole and amide of 1. In accordance with the NMR results, X-ray crystallography of the tetrahydrofuran solvate of 1 showed that hydrogen bond formation occurred between the oxygen atom of tetrahydrofuran and the amide group of 1.
一种新型胆囊收缩素 - A拮抗剂,(S)-N-[1-(2-氟苯基)-3,4,6,7-四氢-4-氧代-吡咯并[3,2,1-jk][1,4]苯并二氮杂卓-3-基]-1H-吲哚-2-甲酰胺(FR120480; 1),是一种手性化合物,其旋光性表现出显著的溶剂依赖性。不仅该化合物旋光度的绝对值,而且其符号(+或-)在不同溶剂中都会改变。1的旋光性与以溶剂给体数表征的给电子性质内在相关。1H NMR研究表明,溶剂的给电子基团与1的吲哚和酰胺的NH基团之间形成了氢键。与NMR结果一致,1的四氢呋喃溶剂化物的X射线晶体学显示,四氢呋喃的氧原子与1的酰胺基团之间形成了氢键。